Keywords: dor, gets, 3m, part, potential, orbec, deal

DOR gets $3M as part of potential orBec deal

Article | 15 January 2007

Print This

Florida, USA-based biopharmaceutical company DOR BioPharma says it has received $3.0 million as part of a non-binding letter of intent from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in